Picture of Ayala Pharmaceuticals logo

ADXS Ayala Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Advaxis Reports Q3 Loss Per Share Of $0.09

Sept 10 (Reuters) - Advaxis Inc  ADXS.O :
    * ADVAXIS REPORTS THIRD QUARTER ENDED JULY 31, 2020
FINANCIAL
RESULTS AND PROVIDES A BUSINESS UPDATE
    * ADVAXIS INC QTRLY  LOSS PER SHARE $0.09
    * ADVAXIS INC -  AS OF JULY 31, 2020 CO HAD ABOUT $23.8
MILLION IN
CASH AND CASH EQUIVALENTS
    * ADVAXIS INC - BELIEVES IT HAS SUFFICIENT CAPITAL TO FUND
ITS
OBLIGATIONS, AS THEY BECOME DUE, IN ORDINARY COURSE OF BUSINESS
UNTIL JULY 2021

Source text for Eikon:  ID:nGNX72xFgs 
Further company coverage:  ADXS.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Ayala Pharmaceuticals

See all news